Actavis PLC news

   Watch this stock
Showing stories 1 - 10 of about 16   

Articles published

Actavis Launches First Generic Equivalent of Requip� XL (Ropinirole Extended ...
MORRISTOWN, N.J., May 18, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Ropinirole Extended-Release Tablets, 2mg, 4mg, 6mg, 8mg and 12mg, a generic ...
Related articles »  
Watson Announces Formation of Global Integration Management Office to ...
"Watson is committed to integrating the combined assets of our Company and Actavis as rapidly and as seamlessly as possible, to recognize the combined potential of the global organization, and to implement appropriate planning and execution processes ...
Related articles »  
Actavis Launches Generic Equivalent of Adalat� CC 90mg (Nifedipine Extended ...
MORRISTOWN, N.J., May 30, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Nifedipine Extended-Release Tablets, USP, 90mg, a generic equivalent to Bayer's ...
Related articles »  
Top ten issues for M&A
There is also the ongoing march of consolidation within the generics and biosimilars market (Watson Pharmaceuticals' acquisition of Actavis being a recent example) as well as originators adding generic capabilities to their product portfolio. Therefore ...
Related articles »  
Shire Looks To Quash Mylan's Generic Colitis Drug
Law360, New York (May 30, 2012, 3:49 PM ET) -- Irish pharmaceutical company Shire Development LLC on Monday hit Mylan Pharmaceuticals Inc. with a patent suit in Florida federal court, launching another attack against a generic-drug maker attempting to ...
Watson settles patent disputes for generic version of Lidoderm with Endo
Recently, the company purchased Swiss-based rival Actavis Group for $5.6 billion, giving the U.S.-based drug maker a boost in the global rankings of generic drug makers to number three.
Related articles »  
A Clear Picture: Decades-Old IMAGe Syndrome Mystery Cracked
Since its discovery nearly 20 years ago, the cause of IMAGe syndrome, a rare disorder that causes stunted growth in babies, has remained a mystery.
Related articles »  
Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
PARSIPPANY, N.J., May 4, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that Lisa M. DeFrancesco has been promoted to the position of Vice President, Global Investor Relations, effective immediately.
Related articles »  
Deals Of The Week: Tolero Introduces Itself In "Double-Jointed" Deal With ...
In a deal structure that perhaps could best be described as �double-jointed,� new company Tolero Pharmaceuticals has licensed exclusive worldwide rights to MannKind Corp.
Eaton To Buy Cooper Industries For $11.8 Bln
Diversified industrial maker Eaton Corp. (ETN: Quote) has agreed to acquire electrical products maker Cooper Industries plc (CBE: Quote) for about $11.8 billion in cash and stock, the two companies said Monday. The companies noted that their ...
Related articles »